Endometriosis and Fertility in 2026: Understanding the Connection and Your Path Forward

Endometriosis affects an estimated 1 in 10 women of reproductive age worldwide — approximately 176 million people globally. Despite its prevalence, it remains one of the most misunderstood, underdiagnosed, and undertreated conditions in gynaecology. The average time from first symptom to diagnosis is still seven to ten years in many countries, a delay that can have profound consequences for fertility.

If you have been diagnosed with endometriosis and are concerned about its impact on your ability to conceive, or if you suspect you may have endometriosis and are wondering about your fertility future, this guide is for you. We will explore what endometriosis is, how it affects fertility, what treatment options are available, and the practical strategies — nutritional, medical, and surgical — that can support your journey toward conception.

What Is Endometriosis? The Biology Behind the Condition

Endometriosis is a chronic inflammatory condition in which tissue similar to the lining of the uterus (the endometrium) grows outside the uterus. These lesions — most commonly found on the ovaries, fallopian tubes, the peritoneum (abdominal lining), and the rectovaginal septum — respond to the monthly hormonal fluctuations of the menstrual cycle, thickening and bleeding with each cycle. Unlike the uterine lining, however, this blood and tissue cannot leave the body, resulting in inflammation, scarring, and the formation of adhesions.

On the ovaries, endometriosis can form cysts filled with dark, "chocolate-coloured" old blood — called endometriomas, or "chocolate cysts." These cysts can grow large enough to distort ovarian anatomy, damage healthy ovarian tissue, and significantly reduce ovarian reserve. In the pelvis, adhesions from repeated cycles of inflammation and healing can bind the ovaries, fallopian tubes, uterus, and bowel together, affecting their normal function and the ability of sperm to reach the egg.

Endometriosis is classified in stages (I through IV) based on the location, extent, and depth of lesions: Stage I (minimal), Stage II (mild), Stage III (moderate), and Stage IV (severe). However, stage does not always correlate with symptom severity or fertility impact. Women with Stage I disease may have severe pain, while women with Stage IV may have minimal symptoms despite extensive disease. Fertility impact does not follow a neat linear pattern either — though higher-stage disease is generally associated with more significant fertility challenges.

How Endometriosis Affects Fertility: Multiple Mechanisms at Work

The relationship between endometriosis and infertility is multifactorial — meaning several different biological mechanisms can operate simultaneously, often compounding each other. Understanding these mechanisms helps explain why endometriosis-related infertility can be complex to treat and why a multidimensional approach is often needed.

Anatomical distortion: In moderate-to-severe disease, adhesions and scar tissue can physically obstruct the fallopian tubes, prevent the tubes from properly sweeping eggs into the tube after ovulation, or fuse the ovaries to adjacent structures. Tubal obstruction prevents sperm from reaching the egg or the fertilised egg from travelling to the uterus. This is the most straightforward mechanism of endometriosis-related infertility and is often the target of surgical treatment.

Ovarian reserve damage: Ovarian endometriomas are directly destructive to ovarian tissue. A systematic review published in Human Reproduction Update found that endometrioma formation reduces the number of primordial follicles in affected ovarian tissue, and that surgical removal of endometriomas carries additional risk of damaging surrounding healthy ovarian tissue. Women with bilateral endometriomas (on both ovaries) may have significantly diminished ovarian reserve as a result.

Inflammatory peritoneal environment: Even in early-stage disease with no apparent anatomical disruption, the peritoneal fluid of women with endometriosis contains elevated levels of inflammatory cytokines, prostaglandins, activated macrophages, and toxic substances including reactive oxygen species. This hostile biochemical environment impairs sperm function, inhibits fertilisation, and may interfere with embryo transport and implantation.

Impaired egg quality: Research has found that women with endometriosis have reduced oocyte competence — meaning their eggs are less capable of successful fertilisation and embryo development. A 2020 study in Fertility and Sterility found that, even in IVF cycles where eggs from women with endometriosis were fertilised with donor sperm, the resulting embryos had lower developmental quality than those from women without endometriosis. This suggests an intrinsic egg quality issue, likely driven by the toxic follicular environment created by endometriosis.

Endometrial receptivity: Endometriosis alters the uterine environment even where no lesions are visible within the uterus itself. Gene expression studies have found that the endometrium in women with endometriosis shows dysregulation during the implantation window — the narrow period when the uterine lining is receptive to an embryo. This impaired receptivity may contribute to lower implantation rates and higher early pregnancy loss in women with endometriosis.

Diagnosing Endometriosis: The Persistent Challenge

One of the most frustrating aspects of endometriosis is the persistent difficulty in achieving a timely diagnosis. Symptoms — pelvic pain, severe menstrual cramps, pain during intercourse, bowel and bladder symptoms — are shared with many other conditions, and are often normalised or dismissed as "part of being a woman." Definitive diagnosis has traditionally required laparoscopy (keyhole surgery with direct visualisation of lesions), which can only be offered when clinical suspicion is sufficient to justify surgical intervention.

Advancements in imaging technology have improved non-surgical diagnosis. Specialist transvaginal ultrasound, performed by an experienced sonographer using specific techniques for endometriosis mapping (the BSGE-recommended approach in the UK, similar in India's leading tertiary centres), can now detect endometriomas, deeply infiltrating lesions, and certain anatomical markers of endometriosis with good accuracy. MRI provides complementary information for deeply infiltrating disease, particularly when bowel or bladder involvement is suspected.

Blood tests for endometriosis biomarkers — most notably CA-125 — have insufficient sensitivity and specificity for routine diagnostic use, though highly elevated CA-125 in a premenopausal woman with pelvic symptoms increases clinical suspicion. Research into more sensitive and specific blood-based biomarkers continues, with several promising candidates in clinical development as of 2026.

For women in India who are concerned about delayed diagnosis, advocating clearly with a specialist — ideally a gynaecologist with specific expertise in endometriosis or a reproductive endocrinologist — is important. Bringing a detailed symptom diary and documenting the impact of pain on daily functioning can support a productive clinical consultation.

Medical and Surgical Treatment Options for Endometriosis-Related Infertility

Treatment of endometriosis for fertility purposes differs from treatment for pain management, and the two goals are not always served by the same approach. Understanding the distinction is essential.

Surgical excision: Laparoscopic excision (cutting out) of endometriosis lesions is the preferred surgical approach for endometriosis-related infertility. A landmark randomised trial (the Canadian Endometriosis Study) found that laparoscopic excision of minimal-to-mild endometriosis doubled the monthly fecundity rate compared to diagnostic laparoscopy alone (4.7% versus 2.4% per cycle). For moderate-to-severe disease, surgery to restore normal anatomy — removing adhesions, unblocking tubes, and excising lesions — can significantly improve natural conception chances and IVF outcomes.

Endometrioma management: The surgical management of ovarian endometriomas before IVF is one of the most debated topics in reproductive medicine. Removal of endometriomas can restore ovarian anatomy, improve egg quality by reducing the toxic biochemical environment, and facilitate ultrasound monitoring and egg retrieval. However, surgery carries a risk of further damaging ovarian reserve. Current ESHRE (European Society of Human Reproduction and Embryology) guidelines recommend surgery for endometriomas greater than 3–4cm before IVF when the cyst is accessible and the patient has not undergone previous ovarian surgery. When previous surgery has already reduced reserve, proceeding directly to IVF without further surgery is often preferable.

Medical suppression: Hormonal medications used for endometriosis (GnRH analogues, combined oral contraceptives, progestins, GnRH antagonists) suppress estrogen and prevent the growth and activity of endometriosis lesions. These medications are effective for pain but are incompatible with active attempts to conceive, as they prevent ovulation. They may be used after surgery to suppress disease before a planned IVF cycle in selected cases.

IVF for endometriosis: IVF is an effective treatment for endometriosis-related infertility, particularly in women with tubal disease, diminished ovarian reserve, or failed surgical treatment. Success rates with IVF in women with endometriosis are somewhat lower than in age-matched women without endometriosis due to impaired egg quality and endometrial receptivity, but IVF remains highly effective and is the standard of care for complex cases. Preimplantation genetic testing (PGT-A) may improve success rates by selecting chromosomally normal embryos for transfer.

Anti-Inflammatory Nutrition for Endometriosis and Fertility

Diet and nutrition play an increasingly recognised role in managing endometriosis and supporting fertility in affected women. Endometriosis is fundamentally an inflammatory condition, and dietary patterns that reduce systemic inflammation can help modulate disease activity and create a more favourable environment for conception.

Key dietary strategies supported by emerging evidence include:

Anti-inflammatory dietary pattern: A diet modelled on Mediterranean principles — rich in vegetables, fruits, legumes, whole grains, oily fish, and olive oil — provides abundant anti-inflammatory omega-3 fatty acids, polyphenols, and antioxidants that help counteract the inflammatory milieu of endometriosis. A 2004 study published in Human Reproduction found that long-term high intake of omega-3 fatty acids was associated with a 22% lower risk of endometriosis, while high intake of trans fats was associated with a 48% higher risk.

Reducing red meat: High consumption of red meat has been associated with increased endometriosis risk in prospective studies, potentially through hormonal mechanisms (red meat contains arachidonic acid, a precursor to pro-inflammatory prostaglandins) and the influence of saturated fat on estrogen metabolism. Limiting red meat to 1–2 portions per week and emphasising plant proteins and fish is commonly recommended by endometriosis specialists.

Cruciferous vegetables: Broccoli, cauliflower, cabbage, kale, and Brussels sprouts contain indole-3-carbinol and diindylmethane (DIM), compounds that support the liver's metabolism of estrogen into less active forms. Since endometriosis is an estrogen-dependent condition, supporting healthy estrogen metabolism may help reduce disease activity. Including 2–4 servings of cruciferous vegetables per week is a simple, safe strategy.

Reducing gluten and dairy: Clinical evidence here is limited, but observational data and patient surveys suggest that a subset of women with endometriosis experience symptom improvement (particularly pain reduction) when reducing gluten or dairy. A 2012 study by Marziali et al. found that 75% of women with endometriosis who followed a gluten-free diet for one year reported significant improvement in pain scores. This is not universal, but elimination trials may be worthwhile for women who don't respond to standard pain management.

Nutritional Supplementation for Endometriosis and Fertility

Several nutrients have specific relevance to both endometriosis management and fertility support in affected women:

Vitamin D: Vitamin D has important immunomodulatory and anti-inflammatory properties, and deficiency has been linked to endometriosis in multiple studies. A 2020 study in Reproductive Sciences found that women with endometriosis had significantly lower vitamin D levels than controls, and that vitamin D supplementation reduced inflammatory markers in affected women. Vitamin D also supports endometrial receptivity — critical in women with endometriosis-related implantation challenges.

Omega-3 fatty acids: EPA and DHA shift the body's prostaglandin balance from pro-inflammatory (arachidonic acid-derived) toward anti-inflammatory pathways, potentially reducing endometriosis-associated inflammation and pain. Studies in animal models of endometriosis have found that omega-3 supplementation reduces lesion volume and inflammatory markers. While human trials are limited, the safety profile and broader fertility benefits of omega-3s make supplementation a reasonable recommendation.

N-acetyl cysteine (NAC): NAC is a precursor to glutathione — the body's master endogenous antioxidant — and has anti-inflammatory properties relevant to endometriosis. A randomised clinical trial published in Evidence-Based Complementary and Alternative Medicine found that NAC significantly reduced the size of ovarian endometriomas over three months compared to placebo, and was associated with a higher proportion of women achieving pregnancy during the follow-up period. While this was a single trial and further research is needed, NAC is increasingly considered by reproductive specialists as an adjunct intervention in endometriosis.

Methylfolate: Essential for DNA synthesis and methylation reactions, methylfolate is important for women with endometriosis both for the management of their condition (folate deficiency impairs immune function and antioxidant defences) and for pre-conception preparation. Women with MTHFR variants benefit from the active methylfolate form.

Magnesium: Magnesium has muscle-relaxant and anti-inflammatory properties and has been studied specifically for menstrual pain — a major symptom of endometriosis. A systematic review found that magnesium was more effective than placebo for reducing menstrual pain, though research specifically in endometriosis is limited. Magnesium also supports sleep quality and stress resilience — both relevant to overall wellbeing in women managing a chronic condition.

Emotional Wellbeing and Support for Women With Endometriosis

The psychological burden of endometriosis should not be underestimated. Living with chronic pain, navigating a lengthy diagnostic journey, managing the uncertainty of fertility impacts, and confronting the financial and physical demands of treatment all take a significant emotional toll. Research published in Human Reproduction found that women with endometriosis have significantly higher rates of anxiety and depression than the general population.

Seeking psychological support — whether through a therapist specialising in chronic illness, a fertility counsellor, or a peer support group — is not an optional extra: it is a legitimate and important component of comprehensive care. Endometriosis India (a patient advocacy organisation) and ESHRE's patient information platform both provide resources and community support.

It is also important for women with endometriosis to know that a diagnosis does not mean infertility is inevitable. Many women with endometriosis conceive naturally or with minimal intervention. Working with a specialist who understands both endometriosis and reproductive medicine, building a comprehensive treatment plan, and seeking the right support network can significantly improve both your health and your path to parenthood.

Frequently Asked Questions About Endometriosis and Fertility

Does endometriosis always cause infertility?

No. Approximately 30–50% of women with endometriosis experience fertility difficulties, but the majority of women with endometriosis are able to conceive — with or without medical assistance. Fertility impact depends on the stage and location of disease, age, partner's sperm health, and other individual factors. Early diagnosis and appropriate management improve outcomes significantly.

Can endometriosis go away on its own?

Endometriosis is a chronic, estrogen-dependent condition that does not resolve spontaneously in most women. It typically regresses during pregnancy and menopause when estrogen levels decline, but returns after pregnancy and can recur after menopause with hormone replacement therapy. Surgical excision reduces lesion burden, but recurrence rates over time are significant — estimated at 20–40% within five years.

Should I have surgery before trying to conceive?

This depends on individual circumstances including the stage of disease, your age, ovarian reserve, and how long you've been trying to conceive. For women with advanced-stage disease, significant anatomical distortion, or large endometriomas, surgical correction may improve natural conception chances and IVF outcomes. For women with minimal disease or those who have already undergone previous ovarian surgery, proceeding to IVF without further surgery may be preferable. This decision should be made with an experienced reproductive specialist.

Does endometriosis affect egg quality?

Yes. Research indicates that women with endometriosis have reduced oocyte competence — their eggs are less capable of successful fertilisation and normal embryo development, likely due to the toxic inflammatory environment in the ovary and follicular fluid. This contributes to lower IVF success rates in women with endometriosis compared to age-matched controls without the condition.

Is IVF effective for endometriosis-related infertility?

IVF is an effective treatment for endometriosis-related infertility, though success rates are somewhat lower than in women without endometriosis — primarily due to egg quality factors. Multiple cycles may be needed. Preimplantation genetic testing (PGT-A) can improve transfer success rates by selecting chromosomally normal embryos. Many women with endometriosis achieve successful pregnancies through IVF.

Can diet help endometriosis?

Dietary modification cannot cure endometriosis, but it can help manage inflammation, support hormonal balance, and contribute to overall reproductive health. An anti-inflammatory dietary pattern (Mediterranean-style), rich in omega-3s, vegetables, and plant proteins, while limiting red meat and processed foods, is supported by emerging evidence. Some women find symptom improvement with gluten or dairy reduction, though this is not universal.

What supplements help with endometriosis?

Supplements with the most supporting evidence for endometriosis management and fertility include vitamin D, omega-3 fatty acids (EPA and DHA), N-acetyl cysteine (NAC), methylfolate, magnesium, and CoQ10. These should complement, not replace, medical treatment, and should be discussed with your healthcare provider.

How does endometriosis affect ovarian reserve?

Ovarian endometriomas (chocolate cysts) directly damage the surrounding ovarian cortex, reducing the pool of primordial follicles. Women with bilateral endometriomas may have significantly reduced AMH levels. Surgical removal of endometriomas carries a further risk of removing healthy ovarian tissue. Regular monitoring of ovarian reserve (AMH and AFC) is recommended for women with known ovarian endometriosis.

When should I seek help for endometriosis-related infertility?

Women with known or suspected endometriosis are generally advised to seek fertility evaluation after 6 months of trying to conceive (rather than the usual 12 months for women under 35 without known conditions). Women over 35 with endometriosis should seek evaluation sooner — ideally before beginning conception attempts, to understand their ovarian reserve and plan accordingly.

Can endometriosis affect pregnancy outcomes after conception?

Women with endometriosis have slightly higher risks of certain pregnancy complications, including preterm birth, placenta praevia, and caesarean section delivery, compared to the general population. Regular antenatal monitoring is appropriate. However, many women with endometriosis have entirely uncomplicated pregnancies and healthy deliveries.